Completed PHASE2 INTERVENTIONAL NCT00699634

Nabilone for the Treatment of Phantom Limb Pain

A Randomized Double-blind Placebo Controlled Trial Assessing the Effect of the Oral Cannabinoid Nabilone on Pain and Quality of Life in Patients With Phantom Limb Pain

Sponsor: University of Manitoba

Conditions Neuropathic Pain Phantom Limb Pain

Interventions Nabilone

Updated 5 times since 2017 Last updated: Apr 28, 2011 Started: Jan 31, 2009 Primary completion: Feb 28, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Neuropathic Pain and Phantom Limb Pain, this trial is completed. The trial is conducted by University of Manitoba and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Manitoba
Valeant Canada Limited

Data source: University of Manitoba

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winnipeg, Canada